Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

Key Takeaways Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine.The shot, ...

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

Robert F. Kennedy Jr. secures a prominent health role, pledging reform in vaccine approval. The FDA plans significant changes ...

JN.1 may not be more severe, but it spreads fast, and that’s reason enough to stay alert. Across Asia, the priority is clear: ...

WHO has presented a budget for the next two years that is 22% less than originally planned, largely in response to U.S. and ...

In the wake of President Trump's decision to withdraw from the World Health Organization, the agency is holding its first ...

Stripped of US funding, the World Health Organisation chief on Monday appealed to member countries to support its “extremely modest” request for a USD 2.1 billion annual budget by putting that sum ...

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet ...